MASS icon

908 Devices

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 80%
Negative

Neutral
Business Wire
5 days ago
908 Devices to Participate in Investor Conferences in March
BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced it will participate in the following investor conferences. TD Cowen 46th Annual Healthcare Conference, Boston, MA Fireside chat on Wednesday, March 4 at 9:10 a.m. Eastern Time Leerink Global Healthcare Conference, Miami, FL Fireside chat on Monday, March 9 at 1:40 p.m.
908 Devices to Participate in Investor Conferences in March
Neutral
Business Wire
12 days ago
908 Devices to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will report financial results for the fourth quarter and full year 2025 before market open on Tuesday, March 3, 2026. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time. Live audio of the webcast will be available on the “.
908 Devices to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
Neutral
Business Wire
24 days ago
908 Devices Enhances MX908 Usability and Adds New Drug Targets
BURLINGTON, Mass.--(BUSINESS WIRE)-- #chemicalID--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces new capabilities for its handheld MX908 mass spectrometry device for trace chemical identification. These enhancements include an updated mission mode for hazardous vapor sampling and the addition of five priority drug targets, providing first responders with intelligence at the point of need for an informed, confident response. The MX908 mission mode.
908 Devices Enhances MX908 Usability and Adds New Drug Targets
Positive
Zacks Investment Research
1 month ago
908 Devices (MASS) Moves 19.2% Higher: Will This Strength Last?
908 Devices (MASS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
908 Devices (MASS) Moves 19.2% Higher: Will This Strength Last?
Neutral
Business Wire
1 month ago
908 Devices Announces Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025
BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced preliminary unaudited financial results for the quarter and full year ended December 31, 2025. Preliminary unaudited revenue for the fourth quarter of 2025 is approximately $17.2 million, compared to $14.3 million in the fourth quarter of 2024, reflecting reported gro.
908 Devices Announces Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025
Neutral
Seeking Alpha
3 months ago
908 Devices Inc. (MASS) Q3 2025 Earnings Call Transcript
908 Devices Inc. ( MASS ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants Barbara Russo - VP of Marketing & Corporate Communications Kevin Knopp - Co-Founder, CEO, President & Director Joseph Griffith - CFO & Treasurer Conference Call Participants Puneet Souda - Leerink Partners LLC, Research Division Matthew Larew - William Blair & Company L.L.C., Research Division Brendan Smith - TD Cowen, Research Division Daniel Arias - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Operator Ladies and gentlemen, thank you for joining us, and welcome to the 908 Devices Third Quarter 2025 Financial Results Conference Call.
908 Devices Inc. (MASS) Q3 2025 Earnings Call Transcript
Negative
Zacks Investment Research
3 months ago
908 Devices Inc. (MASS) Reports Q3 Loss, Tops Revenue Estimates
908 Devices Inc. (MASS) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.23 per share a year ago.
908 Devices Inc. (MASS) Reports Q3 Loss, Tops Revenue Estimates
Neutral
Business Wire
3 months ago
908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended September 30, 2025. “We are pleased with our year-to-date progress as we continue to build a more predictable and profitable business and bring our 908 Devices 2.0 vision to life,” said Kevin J. Knopp, CEO and Co-founder. “Revenue for the f.
908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook
Negative
Zacks Investment Research
3 months ago
Will 908 Devices Inc. (MASS) Report Negative Earnings Next Week? What You Should Know
908 Devices (MASS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will 908 Devices Inc. (MASS) Report Negative Earnings Next Week? What You Should Know
Neutral
Business Wire
4 months ago
908 Devices to Participate in Upcoming Investor Conferences
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced it will participate in the following investor conferences. Stifel Healthcare Conference, New York, NY Fireside chat on Wednesday, November 12 at 8:40 a.m. Eastern Time 27th Annual Stephens Investment Conference, Nashville, TN Fireside chat on Thursday, November 20 at 10 a.m. Cen.
908 Devices to Participate in Upcoming Investor Conferences